Health Network Spans 5 Western United States Serving 22,000 New
Cancer Patients and 100,000 Cancer Cases Per Year.
Partnership installs Illumina HiSeq X Ten sequencing system enabling
the nation’s first clinical whole genome sequencing paired with
RNA-sequencing and proteomics.
NantHealth’s clinical operating system combined with a fully integrated genomic, transcriptomic analytic super computer, capable of identifying alteration spanning from DNA to RNA to protein pathways, is capable of integrating the genetic data from a tumor sample in 47 seconds and transferring the data in 18 seconds. This capability, along with the HiSeq X Ten system, will enable
“Our super-computer-driven analysis represents more than just cutting edge 21st-century clinical decision support representing the next chapter in the medical community’s fight against disease,” said Dr. Soon-Shiong. “We are now able to better understand the depth and extent of analysis required to deliver more targeted, effective and efficient treatment for patients.”
“Through this partnership, we are radically improving accuracy. Doctors will have the information to meaningfully transform the lives of our patients by giving them a real chance of beating cancer,” said Dr.
The HiSeq X Ten is the world’s first platform to deliver population-scale whole genome sequencing, and is capable of sequencing thousands of samples annually with high-quality.
We are thrilled to partner with
A 501c(3) non-profit medical research organization focused on transforming medical practice by facilitating digital molecular diagnosis. IOMM is building a public private coalition dedicated to working with health care, academic, government, and private sector partners to enable evidence based and molecularly driven, clinical decisions.
NantHealth is a transformational healthcare company converging science and technology through a single integrated clinical platform. Through the convergence of cloud-based supercomputers, intelligent sensors, machine to machine wireless interconnectivity, artificial intelligence and federated secure grid computing, NantHealth has launched the next generation advanced population health management system. The company’s platform empowers physicians, patients, payers and researchers to transcend the traditional barriers of today’s healthcare system. For more information please visit www.nanthealth.com and follow Dr. Soon-Shiong on Twitter @solvehealthcare.
NantOmics is a leading medical omics company dedicated to providing actionable intelligence and molecularly driven decision support for cancer patients and their providers at point of care. NantOmics is the first molecular omics company to pioneer an integrated approach which unearths the genomic and proteomic variances that initiate and drive cancer, by analyzing both normal and tumor cells from the same patient, from DNA to RNA to protein to drug. For more information please visit www.nantomics.com and follow Dr. Soon-Shiong on Twitter @solvehealthcare.
Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its applications, paving the way for molecular medicine and ultimately transforming healthcare.